In this work, we have assessed methylation status of the promoter regions of the integrin, dystroglycan, and nidogen genes, and have evaluated the association of their abnormal hypermethylation with expression and epigenetic subtypes of breast cancer. This evidence concerns the gene DAG1 and breast cancer.